Clinical Trial Update: Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Clinical trial update noting the completion of a Phase 2 study of MEDI-522 administered subcutaneously to adults with plaque psoriasis. The trial was sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• MEDI-522

Snippet

Sponsor: MedImmune LLC | Conditions: Psoriasis | Phase 2 | Status: COMPLETED